PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsNitrazepam
Nitrazepam
Nitrazepam is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
N05: Psycholeptics
N05C: Hypnotics and sedatives
N05CD: Benzodiazepine derivative hypnotics and sedatives
N05CD02: Nitrazepam
HCPCS
No data
Clinical
Clinical Trials
12 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
EpilepsyD004827EFO_0000474G40.9123
Intellectual disabilityD008607EFO_0003847F7311
Drug resistant epilepsyD00006927911
Drug-related side effects and adverse reactionsD064420T88.711
Indications Phases 3
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Heart failureD006333EFO_0003144I5011
Vascular diseasesD014652EFO_0004264I7711
SpasmD013035M62.8311
Infantile spasmsD013036EFO_1000643G40.8211
Nerve blockD009407111
AnxietyD001007EFO_0005230F41.1111
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Autism spectrum disorderD000067877F84.011
CarcinomaD002277C80.011
Hepatocellular carcinomaD006528C22.011
Therapeutic chemoembolizationD01646111
Rheumatoid arthritisD001172EFO_0000685M06.911
ArthritisD001168EFO_0005856M05-M1411
Chronic painD05935011
Colorectal neoplasmsD01517911
NeoplasmsD009369C8011
Liver neoplasmsD008113EFO_1001513C22.011
Show 1 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNitrazepam
INNnitrazepam
Description
Nitrazepam is a 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome). It has a role as an anticonvulsant, an antispasmodic drug, a GABA modulator, a sedative and a drug metabolite. It is a 1,4-benzodiazepinone and a C-nitro compound.
Classification
Small molecule
Drug classantianxiety agents (diazepam type)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1
Identifiers
PDB
CAS-ID146-22-5
RxCUI
ChEMBL IDCHEMBL13209
ChEBI ID7581
PubChem CID4506
DrugBankDB01595
UNII ID9CLV70W7HS (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 2,727 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
3,206 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use